BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18430340)

  • 1. Gastric cancer surgery--a balance of risk and radicality.
    Lamb P; Sivashanmugam T; White M; Irving M; Wayman J; Raimes S
    Ann R Coll Surg Engl; 2008 Apr; 90(3):235-42. PubMed ID: 18430340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
    Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
    J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal extent of lymphadenectomy for gastric adenocarcinoma: A 7-institution study of the U.S. gastric cancer collaborative.
    Randle RW; Swords DS; Levine EA; Fino NF; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Pawlik TM; Jin LX; Spolverato G; Schmidt C; Worhunsky D; Cho CS; Maithel SK; Votanopoulos KI
    J Surg Oncol; 2016 Jun; 113(7):750-5. PubMed ID: 26996496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
    Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
    Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of superextended lymphadenectomy (D4) in gastric cancer].
    Pugliese R; Maggioni D; Sansonna F; Scandroglio I; Di Lernia S; Boniardi M; Bramerio MA
    Minerva Chir; 2004 Aug; 59(4):325-35. PubMed ID: 15278027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome after D1 vs D2-3 gastrectomy for treatment of gastric cancer.
    Danielson H; Kokkola A; Kiviluoto T; Sirén J; Louhimo J; Kivilaakso E; Puolakkainen P
    Scand J Surg; 2007; 96(1):35-40. PubMed ID: 17461310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.
    Songun I; Putter H; Kranenbarg EM; Sasako M; van de Velde CJ
    Lancet Oncol; 2010 May; 11(5):439-49. PubMed ID: 20409751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgical outcome of 801 patients with localized gastric cancer treated with d2 lymphadenectomy].
    Ruiz E; Sanchez J; Celis J; Payet E; Berrospi F; Chavez I; Young F
    Rev Gastroenterol Peru; 2009; 29(2):124-31. PubMed ID: 19609327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical outcomes of gastrectomy with D1 lymph node dissection performed for patients with unfavorable clinical conditions.
    Ramos MFKP; Pereira MA; Dias AR; Yagi OK; Zaidan EP; Ribeiro-Júnior U; Zilberstein B; Cecconello I
    Eur J Surg Oncol; 2019 Mar; 45(3):460-465. PubMed ID: 30497814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of bursectomy on operative morbidity and mortality after radical gastrectomy for gastric cancer: results of a randomized controlled trial.
    Imamura H; Kurokawa Y; Kawada J; Tsujinaka T; Takiguchi S; Fujiwara Y; Mori M; Doki Y
    World J Surg; 2011 Mar; 35(3):625-30. PubMed ID: 21161652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
    Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
    Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.
    Cuschieri A; Fayers P; Fielding J; Craven J; Bancewicz J; Joypaul V; Cook P
    Lancet; 1996 Apr; 347(9007):995-9. PubMed ID: 8606613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Morbidity and mortality in gastric cancer surgery--analysis of 468 cases with gastric adenocarcinoma].
    Necula A; Vlad L; Iancu C; Munteanu D; Puia C; Bălă O; AlHajaar N; Pop F; Radu H; Osian G; Graur F; Furcea L; Stanca M; Molnar G; Mocanu L
    Chirurgia (Bucur); 2008; 103(5):529-37. PubMed ID: 19260628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenocarcinoma of the gastric antrum: does D2 total gastrectomy with splenectomy improve prognosis compared to D1 subtotal gastrectomy? A long-term survival analysis with emphasis on Lauren classification.
    Roukos D; Schmidt-Mathiesen A; Encke A
    Surg Oncol; 1995; 4(6):323-32. PubMed ID: 8809955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501.
    Sano T; Sasako M; Yamamoto S; Nashimoto A; Kurita A; Hiratsuka M; Tsujinaka T; Kinoshita T; Arai K; Yamamura Y; Okajima K
    J Clin Oncol; 2004 Jul; 22(14):2767-73. PubMed ID: 15199090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.
    Norero E; Bustos M; Herrera ME; Cerda J; González P; Ceroni M; Martínez C; Briceño E; Rojas H; Cártes R; Lopez V; Hidalgo V; Báez S; Caracci M; Viñuela E; Díaz A
    Eur J Surg Oncol; 2016 Jan; 42(1):94-102. PubMed ID: 26577767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes.
    Volpe CM; Driscoll DL; Douglass HO
    Ann Surg Oncol; 2000 Mar; 7(2):139-44. PubMed ID: 10761793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment of gastric cancer: a 10-year experience in a high-volume university hospital.
    Ramos MFKP; Pereira MA; Yagi OK; Dias AR; Charruf AZ; Oliveira RJ; Zaidan EP; Zilberstein B; Ribeiro-Júnior U; Cecconello I
    Clinics (Sao Paulo); 2018 Dec; 73(suppl 1):e543s. PubMed ID: 30540120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for gastrectomy with D2 lymphadenectomy in the treatment of gastric cancer.
    Díaz de Liaño A; Yarnoz C; Aguilar R; Artieda C; Ortiz H
    Gastric Cancer; 2008; 11(2):96-102. PubMed ID: 18595016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of survival outcome following radical gastrectomy for gastric cancer.
    Lui SA; Tan WB; Tai BC; Yong WP; Mu YS; Ti TK; Shabbir A; So J
    ANZ J Surg; 2019 Jan; 89(1-2):84-89. PubMed ID: 30690932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.